E626

E626

SCHEMBL25249751

Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1.O=P(O)(O)OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 1/20 0.77
▸ TGM2 P21980 1/20 0.77
▸ IMPDH2 P12268 7/20 0.71
▸ IMPDH1 P20839 2/20 0.71
▸ KRAS P01116 5/20 0.69
▸ FUT5 Q11128 1/20 0.69
▸ TAS1R3 Q7RTX0 1/20 0.68
▸ TAS1R1 Q7RTX1 1/20 0.68
▸ P2RY2 P41231 1/20 0.65
▸ P2RY4 P51582 1/20 0.65
▸ P2RY6 Q15077 1/20 0.65
▸ HINT1 P49773 1/20 0.64
▸ P2RX3 P56373 1/20 0.64
▸ CA5A P35218 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37405 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
Triphosphate SCHEMBL28597197 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL17072523 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL23969756 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL80058 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL101367 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL18775378 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL18785111 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
SCHEMBL13210265 0.96 TGM2 (0.82) NT5ETGM2IMPDH2IMPDH1KRAS
E626 SCHEMBL21803790 0.96 NT5E (0.83) NT5ETGM2IMPDH2IMPDH1KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116575-A1 ADAPTER FOR CHARACTERIZING TARGET POLYNUCLEOTIDE, METHOD, AND USE THEREOF 成都齐碳科技有限公司 2023-06-29 — — WO disclosed
Send feedback